ERBB2 and breast cancer: At The Christie NHS Foundation Trust (The Christie), docetaxel (T) carboplatin (C) trastuzumab (H) pertuzumab (P) (TCHP) is a commonly used neoadjuvant regimen for patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer.